Primary Site >> Esophagus Cancer
Gene >> TNFSF10
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer. PMID: 11890101 Ref: [Phase III clinical study of a new anticancer drug atofluding]. PMID: 12520746 |
Ref: Targeting Bcl-xL in esophageal squamous cancer to sensitize to chemotherapy plus TRAIL-induced apoptosis while normal epithelial cells are protected by blockade of caspase 9. PMID: 14752513 |
Ref: Staging and treatment of advanced esophageal cancer. PMID: 15930991 Ref: [Is the invasive approach for all the upper gastrointestinal mesenchymal tumors necessary?]. PMID: 15973072 Ref: ZD1839 (Gefitinib, 'Iressa'), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma. PMID: 16023108 |
Ref: Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatin. PMID: 17172403 |
Ref: Genomic profiling of 766 cancer-related genes in archived esophageal normal and carcinoma tissues. PMID: 18241037 Ref: Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. PMID: 18451249 Ref: Synergistic apoptotic effects of taurolidine and TRAIL on squamous carcinoma cells of the esophagus. PMID: 18497982 |
Ref: Definitive concomitant chemoradiotherapy with docetaxel and cisplatin in squamous esophageal carcinoma. PMID: 19732130 |
Ref: Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: A meta-analysis of 17 case-control studies. PMID: 23226753 |
Ref: Esophageal cancer-selective expression of TRAIL mediated by MREs of miR-143 and miR-122. PMID: 24659424 Ref: Human mesenchymal stem cells with adenovirus-mediated TRAIL gene transduction have antitumor effects on esophageal cancer cell line Eca-109. PMID: 24739635 Ref: Licochalcone-A sensitizes human esophageal carcinoma cells to TRAIL-mediated apoptosis by proteasomal degradation of XIAP. PMID: 25436288 Ref: Licochalcone-A sensitizes human esophageal carcinoma cells to TRAIL-mediated apoptosis by proteasomal degradation of XIAP. PMID: 25513073 |
Ref: Editorial. PMID: 26520390 |
Ref: Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation. PMID: 27731378 |
Ref: Correlation between Electroencephalogram Alterations and Frontal Cognitive Impairment in Esophageal Cancer Patients Complicated with Depression. PMID: 28748850 Ref: CCN1 sensitizes esophageal cancer cells to TRAIL-mediated apoptosis. PMID: 29055676 Ref: What is the optimal radiation dose for non-operable esophageal cancer? Dissecting the evidence in a meta-analysis. PMID: 29179502 |
Ref: Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial. PMID: 29306867 |